Drug Search

Search the NC formulary database by brand name, generic name, drug class, or active ingredient. Search tips

Informational only — Formulary data may be inaccurate or outdated. Always verify with official plan documents, your pharmacy, or your clinician before acting.

22 results for "ONCOLOGICAL AGENTS"

Drug Name Generic Name Strength Form Plans Covering Actions
Bosulif
Brand for bosutinib
ANTINEOPLASTICS
Also: Bosulif Oral Capsule, bosutinib, BOSULIF CAPS 50MG, 100MG; TABS 100MG, 400MG, 500MG, Bosulif 50 Mg Capsule, Bosulif 100 Mg Capsule, Bosulif 100 Mg Tablet, Bosulif 400 Mg Tablet, Bosulif 500 Mg Tablet, BOSULIF CAPS 50MG, 100MG; TABS 100MG,
bosutinib 50MG, 100MG Capsule 153 plans Details
Danziten
Brand for nilotinib
ANTINEOPLASTIC ENZYME INHIBITORS
Also: nilotinib, DANZITEN TABS 71MG, 95MG
nilotinib 71MG, 95MG Tablet 135 plans Details
Ensacove
Brand for ensartinib
ANTINEOPLASTICS
Also: ensartinib, ENSACOVE CAPS 25MG, 100MG
ensartinib 25MG, 100MG Capsule 147 plans Details
Gomekli
Brand for mirdametinib
ANTINEOPLASTICS
Also: mirdametinib, GOMEKLI CAPS 1MG, 2MG; TBSO 1MG
mirdametinib 1MG, 2MG Capsule 150 plans Details
Hernexeos
Brand for zongertinib
Kinase Inhibitor
Also: zongertinib, HERNEXEOS TABS 60MG
zongertinib 60 MG Tablet 148 plans Details
Ibtrozi
Brand for taletrectinib
ANTINEOPLASTICS
Also: taletrectinib, IBTROZI CAPS 200MG
taletrectinib 200 MG Capsule 147 plans Details
Inluriyo
Brand for imlunestrant
4gm/dose
Also: INLURIYO TABS 200MG, imlunestrant
imlunestrant 200 MG Tablet 143 plans Details
Modeyso
Brand for dordaviprone
ANTINEOPLASTICS
Also: dordaviprone, MODEYSO CAPS 125MG
dordaviprone 125 MG Capsule 148 plans Details
Revuforj
Brand for revumenib
ANTINEOPLASTICS
Also: revumenib, REVUFORJ TABS 25MG, REVUFORJ TABS 25MG, 110MG, 160MG
revumenib 25MG, 110MG, 160MG Tablet 150 plans Details
Romvimza
Brand for vimseltinib
ANTINEOPLASTICS
Also: vimseltinib, ROMVIMZA CAPS 14MG, 20MG, 30MG
vimseltinib 14MG, 20MG, 30MG Capsule 150 plans Details
avutometinib potassium/defactinib hydrochloride
ONCOLOGICAL AGENTS
Also: AVMAPKI-FAKZYNJA
0.8 mg-200 mg Pack 1 plan Details
bosutinib
Brand for Bosulif
ONCOLOGICAL AGENTS
Also: BOSULIF
Bosulif 100 mg, 50 mg Capsule 1 plan Details
dordaviprone HCl
ONCOLOGICAL AGENTS
Also: MODEYSO
125 mg Capsule 1 plan Details
ensartinib hydrochloride
ONCOLOGICAL AGENTS
Also: ENSACOVE
100 mg, 25 mg Capsule 1 plan Details
imlunestrant tosylate
ONCOLOGICAL AGENTS
Also: INLURIYO
200 mg Tablet 1 plan Details
mirdametinib
Brand for Gomekli
ONCOLOGICAL AGENTS
Also: GOMEKLI
Gomekli 1 mg, 2 mg Capsule 1 plan Details
nilotinib d-tartrate
ONCOLOGICAL AGENTS
150 mg, 200 mg, 50 mg Capsule 1 plan Details
nilotinib tartrate
ONCOLOGICAL AGENTS
Also: DANZITEN
71 mg, 95 mg Tablet 1 plan Details
revumenib citrate
ONCOLOGICAL AGENTS
Also: REVUFORJ
110 mg, 160 mg, 25 mg Tablet 1 plan Details
taletrectinib adipate
ONCOLOGICAL AGENTS
Also: IBTROZI
200 mg Capsule 1 plan Details
vimseltinib
Brand for Romvimza
ONCOLOGICAL AGENTS
Also: ROMVIMZA
Romvimza 14 mg, 20 mg, 30 mg Capsule 1 plan Details
zongertinib
Brand for Hernexeos
ONCOLOGICAL AGENTS
Also: HERNEXEOS
Hernexeos 60 mg Tablet 1 plan Details
Something not right?